falsefalse

Advanced Prostate Cancer: PSMA-Targeted Radioligand Therapies - Episode 1

Prostate Cancer Disease Complexity and Testing

Neal Shore, MD, discusses the complexity of prostrate cancer and factors to consider when determining management strategies.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: Prostate Cancer Disease Complexity and Testing
    EP. 2: Genotypic and Phenotypic Biomarkers in Prostate Cancer
    EP. 3: Diagnostic and Therapeutic Applications of PSMA in Prostate Cancer
    EP. 4: Use of PSMA PET Scans in Advanced Prostate Cancer
    EP. 5: The VISION Study of 177Lu-PSMA-617 in mCRPC
    EP. 6: Future Directions With PSMA Ligand–Directed Therapies

    Related Content:

    Advanced Prostate Cancer: PSMA-Targeted Radioligand TherapiesProstate Cancer
    Expanded FDA Approval Broadens the Role of Lutetium Lu 177 Vipivotide Tetraxetan in PSMA+ mCRPC
    Dr Yu on Factors for PARP Inhibitor Decision-Making in Metastatic Prostate Cancer
    Five Under 5: Top Oncology Videos for the Week of 3/30
    x